Proxy Votes Now

Home › Funds › Equitable › 1290 VT Micro Cap Portfolio

1290 VT Micro Cap Portfolio proxy voting record 2025-2026

Fund family: Equitable · Filed by EQ ADVISORS TRUST (CIK 1027263) · SEC series S000044688

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 9,840 with, 18 against, 0 abstentions (not counted as with management); 3 items carried no recommendation; 10 split votes are in neither count. Shareholder proposals: 4 FOR, 9 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Equitable as a whole

The same two figures as Equitable’s manager page (393,894 ballot items across 72 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsEquitableItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)90.6%9,47292.5%339,726
Backed environmental and social shareholder proposals at US companiesn/a19.6%3,486

Where this fund voted differently from most Equitable funds

Each ballot item this fund voted is set against the votes of the other Equitable funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Equitable funds on 17 items (0.2% of the 7,168 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Equitable fundsMgmtResult
OSI Systems, Inc.2025-12-11Advisory vote to approve the Company's named executive officer compensation for the fiscal year ended June 30, 2025.AgainstFOR — 8 of 8 Equitable fundsAgainstPassed (calculated), 81.0% support
Calix, Inc.2026-05-14Shareholder To hold an advisory vote on a stockholder proposal relating to a simple majority vote.AgainstFOR — 8 of 8 Equitable fundsForPassed (calculated), 90.8% support
Genius Sports Limited2025-12-10Re-elect Daniel Burns as DirectorForAGAINST — 7 of 7 Equitable fundsFor—
Navan, Inc.2026-06-25The election of the three Class I director nominees listed below: Ben HorowitzForWITHHOLD — 5 of 5 Equitable fundsForElected, 98.3% support
Navan, Inc.2026-06-25The election of the three Class I director nominees listed below: Michael KoureyForWITHHOLD — 5 of 5 Equitable fundsForElected, 98.4% support
Kestra Medical Technologies, Ltd.2025-09-03The approval of the Kestra Medical Technologies, Ltd. 2025 Employee Stock Purchase Plan.ForAGAINST — 4 of 6 Equitable fundsFor—
GPGI, Inc.2026-06-11Election of Directors: Brian F. HughesWithholdFOR — 5 of 9 Equitable fundsAgainstPassed (calculated), 97.8% support
10x Genomics, Inc.2026-06-04Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualificatioAgainstFOR — 4 of 7 Equitable fundsAgainstPassed (calculated), 86.6% support
Mirum Pharmaceuticals, Inc.2026-06-15To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Lon Cardon, Ph.D., FMedSciWithholdFOR — 4 of 7 Equitable fundsAgainstElected, 85.3% support
Mirum Pharmaceuticals, Inc.2026-06-15To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: William FaireyWithholdFOR — 4 of 7 Equitable fundsAgainstElected, 86.8% support
Calix, Inc.2026-05-14To elect each of the three director nominees named in the proxy statement: Kathleen CruscoForWITHHOLD — 4 of 7 Equitable fundsForPassed (calculated), 90.7% support
Xometry, Inc.2026-06-16To elect three Class II directors, each to hold office until the Company's Annual Meeting of Stockholders in 2029: Fabio RosatiWithholdFOR — 3 of 5 Equitable fundsAgainstElected, 90.0% support
Xometry, Inc.2026-06-16To elect three Class II directors, each to hold office until the Company's Annual Meeting of Stockholders in 2029: Katharine WeymouthWithholdFOR — 3 of 5 Equitable fundsAgainstElected, 86.7% support
The Chefs' Warehouse, Inc.2026-05-08Election of Directors: Aylwin LewisForAGAINST — 3 of 5 Equitable fundsForPassed (calculated), 73.2% support
The Chefs' Warehouse, Inc.2026-05-08To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the 2026 Proxy Statement.ForAGAINST — 3 of 5 Equitable fundsForApproved, 51.0% support
Sphere Entertainment Co.2026-06-10Election of the following nominees as directors: Debra G. PerelmanWithholdFOR — 2 of 3 Equitable fundsAgainstElected, 81.7% support
Sphere Entertainment Co.2026-06-10Election of the following nominees as directors: Joel M. LitvinWithholdFOR — 2 of 3 Equitable fundsAgainstElected, 81.6% support

Download all 17 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 69.3% of this fund’s 9,858 such votes could be given a sector; the other 3,027 (30.7%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance1,68440.2%
Health Care1,44010.1%
Consumer Discretionary1,21160.5%
Industrials78600.0%
Technology73320.3%
Real Estate29410.3%
Energy18800.0%
Utilities12900.0%
Basic Materials12700.0%
Consumer Staples9933.0%
Telecommunications8500.0%
Miscellaneous5500.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections6,3768
Audit-related1,2740
Say-on-Pay1,1680
Compensation4930
Corporate Governance3244
Capital Structure2442
Extraordinary Transactions1243
Shareholder Rights and Defenses380
Other110
Other Social Issues30

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Adaptive Biotechnologies CorporationJune 5, 2026$5M40
Cogent Biosciences, Inc.June 9, 2026$3M50
Lindblad Expeditions Holdings, Inc.June 10, 2026$3M60
Praxis Precision Medicines, Inc.June 10, 2026$3M50
Tarsus Pharmaceuticals, Inc.June 25, 2026$3M60
10x Genomics, Inc.June 4, 2026$2M50
CRA International, Inc.July 17, 2025$2M40
Navan, Inc.June 25, 2026$2M40

Notable votes against management

MeetingCompanyProposalFundMgmt
July 30, 2025Grindr Inc.Stockholder proposal regarding adoption of a human rights policy covering freedom of association and collective bargaining. Shareholder proposalAgainstFor
May 14, 2026Calix, Inc.To hold an advisory vote on a stockholder proposal relating to a simple majority vote. Shareholder proposalAgainstFor
May 26, 2026El Pollo Loco Holdings, Inc.A Shareholder Proposal requesting the Adoption of a Majority Voting Standard for the Election of Directors in Uncontested Elections. Shareholder proposalForAgainst
May 26, 2026Bel Fuse Inc.With respect to a shareholder proposal requesting that our board of directors take all necessary steps to provide the holders of Class A Common Stock with the right to convert their shares into Class B Common Stock at their option at any time, if properly presented at the Annual Meeting Shareholder proposalAgainstFor
June 9, 2026Medallion Financial Corp.ELECTION OF DIRECTORS - TO ELECT THREE (3) CLASS III DIRECTORS, EACH FOR A TERM EXPIRING AT THE 2029 ANNUAL MEETING OF STOCKHOLDERS ZIMCAL ASSET MANAGEMENT LLC, NOMINEES: Eric Kelly Shareholder proposalWithholdFor
June 9, 2026Medallion Financial Corp.ELECTION OF DIRECTORS - TO ELECT THREE (3) CLASS III DIRECTORS, EACH FOR A TERM EXPIRING AT THE 2029 ANNUAL MEETING OF STOCKHOLDERS ZIMCAL ASSET MANAGEMENT LLC, NOMINEES: John Kiernan Shareholder proposalForAgainst
June 2, 2026NexPoint Diversified Real Estate TrustIf properly presented at the annual meeting, to vote on the shareholder proposal presented under the heading "Shareholder Proposal" in the proxy statement. a. Please note the board is recommending a vote against the shareholder proposal. Shareholder proposalAgainstFor
December 29, 2025Lifeway Foods, Inc.Election of Directors: Opposition Nominees: George Sent Shareholder proposalWithholdFor
December 29, 2025Lifeway Foods, Inc.Election of Directors: Opposition Nominees: Edward Smolyansky Shareholder proposalWithholdFor
June 18, 2026Genco Shipping & Trading LimitedElection of Directors Diana Nominees OPPOSED by the Company: Paul Cornell Shareholder proposalWithholdFor
June 18, 2026Genco Shipping & Trading LimitedElection of Directors Diana Nominees OPPOSED by the Company: Jens Ismar Shareholder proposalWithholdFor
May 29, 2026Forte Biosciences, Inc.To elect three (3) Class III directors to hold office until our 2029 annual meeting of stockholders and until his or her respective successors are elected and qualified: Steven KornfeldForAgainst

Contested meetings

Meetings with a proxy contest or competing nominees (4 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

10,058 ballot items at 1,441 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, 1290 VT Micro Cap Portfolio voted at 1,441 shareholder meetings of 1,338 companies, on 10,058 ballot items in all. Where management made a recommendation, the fund followed it on 99.8% of the items and voted against it 18 times. Its most frequent area of disagreement was director elections (8 of its votes against management). It voted on 19 shareholder proposals. It voted FOR the board's own proposals less often than Equitable's funds as a whole (90.6% against 92.5%). It voted differently from most Equitable funds on 17 items. 4 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Equitable’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.